Dr. Michael Seo is chief technology officer at Fermat. Michael joined Fermat in 2005 and has over 20 years of experience in commercially applied mathematical modelling. Michael brings to the firm a background in software development, signal processing, and image recognition and classification algorithms. Prior to joining his brothers at Fermat, he was director of software and algorithm development for a cellular analysis company (Amnis Corporation, Seattle). Before Amnis Michael was part of the pattern recognition team whose algorithms were core to the first FDA-approved, fully-automated cancer screening device (NeoPath/TriPath, Redmond, Washington). Michael received a Ph.D. in electrical engineering from the University of Texas at Austin (1993) and B.S. degrees in electrical engineering, computer science and mathematics (triple major) from Southern Methodist University (1986).